BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20576750)

  • 21. Dissemination of SHV-12 and CTX-M-type extended-spectrum beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea.
    Ryoo NH; Kim EC; Hong SG; Park YJ; Lee K; Bae IK; Song EH; Jeong SH
    J Antimicrob Chemother; 2005 Oct; 56(4):698-702. PubMed ID: 16141280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extended-spectrum beta-lactamases in ceftazidime-resistant Escherichia coli and Klebsiella pneumoniae isolates in Turkish hospitals.
    Hoşoğlu S; Gündes S; Kolayli F; Karadenizli A; Demirdağ K; Günaydin M; Altindis M; Caylan R; Ucmak H
    Indian J Med Microbiol; 2007 Oct; 25(4):346-50. PubMed ID: 18087082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predominance of CTX-M-15 extended spectrum beta-lactamases in diverse Escherichia coli and Klebsiella pneumoniae from hospital and community patients in Kuwait.
    Ensor VM; Jamal W; Rotimi VO; Evans JT; Hawkey PM
    Int J Antimicrob Agents; 2009 May; 33(5):487-9. PubMed ID: 19097760
    [No Abstract]   [Full Text] [Related]  

  • 24. [Epidemiological study on extended-spectrum beta-lactamase-producing in clinical isolates and selection of antibacterial drugs in China ].
    Yu YS
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(22):1918-20. PubMed ID: 15631810
    [No Abstract]   [Full Text] [Related]  

  • 25. Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.
    Denisuik AJ; Lagacé-Wiens PR; Pitout JD; Mulvey MR; Simner PJ; Tailor F; Karlowsky JA; Hoban DJ; Adam HJ; Zhanel GG;
    J Antimicrob Chemother; 2013 May; 68 Suppl 1():i57-65. PubMed ID: 23587779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surveillance of community-based reservoirs reveals the presence of CTX-M, imported AmpC, and OXA-30 beta-lactamases in urine isolates of Klebsiella pneumoniae and Escherichia coli in a U.S. community.
    Hanson ND; Moland ES; Hong SG; Propst K; Novak DJ; Cavalieri SJ
    Antimicrob Agents Chemother; 2008 Oct; 52(10):3814-6. PubMed ID: 18663030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distribution of acquired AmpC β-lactamase genes in Sydney, Australia.
    Tagg KA; Ginn AN; Jiang X; Ellem J; Partridge SR; Iredell JR
    Diagn Microbiol Infect Dis; 2015 Sep; 83(1):56-8. PubMed ID: 26099646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term study of the frequency of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
    Romero L; López L; Rodríguez-Baño J; Ramón Hernández J; Martínez-Martínez L; Pascual A
    Clin Microbiol Infect; 2005 Aug; 11(8):625-31. PubMed ID: 16008614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from the community in Morocco.
    Barguigua A; El Otmani F; Talmi M; Bourjilat F; Haouzane F; Zerouali K; Timinouni M
    J Med Microbiol; 2011 Sep; 60(Pt 9):1344-1352. PubMed ID: 21546559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multicentre investigation of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in Bulgarian hospitals - Interregional spread of ST11 NDM-1-producing K. pneumoniae.
    Markovska R; Stoeva T; Boyanova L; Stankova P; Schneider I; Keuleyan E; Mihova K; Murdjeva M; Sredkova M; Lesseva M; Nedelcheva G; Petrova A; Ivanova D; Lazarova G; Kaneva R; Mitov I
    Infect Genet Evol; 2019 Apr; 69():61-67. PubMed ID: 30654179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.
    Palasubramaniam S; Muniandy S; Navaratnam P
    J Microbiol Immunol Infect; 2009 Apr; 42(2):129-33. PubMed ID: 19597644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prevalence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae among clinical isolates from a general hospital in Iran.
    Bazzaz BS; Naderinasab M; Mohamadpoor AH; Farshadzadeh Z; Ahmadi S; Yousefi F
    Acta Microbiol Immunol Hung; 2009 Mar; 56(1):89-99. PubMed ID: 19388560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Class 1 integrons in urinary isolates of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Southern China during the past five years.
    Sun J; Zheng F; Wang F; Wu K; Wang Q; Chen Q; Yu S; Rui Y
    Microb Drug Resist; 2013 Aug; 19(4):289-94. PubMed ID: 23573964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence study on carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolates in Czech hospitals--results from Czech Part of European Survey on Carbapenemase--Producing Enterobacteriaceae (EuSCAPE).
    Hrabák J; Študentová V; Jakubů V; Adámková V; Dvořáková L; Balejova M; Bergerová T; Chmelařová E; Ježek P; Kabelíková P; Kolář M; Paterová P; Tejkalová R; Papagiannitsis C; Žemličková H
    Epidemiol Mikrobiol Imunol; 2015 Jun; 64(2):87-91. PubMed ID: 26099612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extended spectrum beta lactamase (ESBL) producing Escherichia coli and klebsiella pneumoniae in diabetic foot infection.
    Varaiya A; Dogra J; Kulkarni M; Bhalekar P
    Indian J Med Microbiol; 2008; 26(3):281-2. PubMed ID: 18695337
    [No Abstract]   [Full Text] [Related]  

  • 36. Escherichia coli ST502 and Klebsiella pneumoniae ST11 sharing an IncW plasmid harbouring the bla(KPC-2) gene in an Intensive Care Unit patient.
    Almeida AC; de Sá Cavalcanti FL; Vilela MA; Gales AC; de Morais MA; Camargo de Morais MM
    Int J Antimicrob Agents; 2012 Oct; 40(4):374-6. PubMed ID: 22817916
    [No Abstract]   [Full Text] [Related]  

  • 37. Long-term study of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
    Polwichai P; Trakulsomboon S; Dejsirilert S; Thongmali O; Sawanpanyalert P; Aswapokee N; Buppanharun W
    J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S53-8. PubMed ID: 21294502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.
    Shanthi M; Sekar U
    J Assoc Physicians India; 2010 Dec; 58 Suppl():41-4. PubMed ID: 21568008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hospital and community-acquired β-lactamases-producing Escherichia coli and Klebsiella pneumoniae at hospitals in Hermosillo, Sonora].
    Navarro-Navarro M; Robles-Zepeda RE; Garibay-Escobar A; Ruiz-Bustos E
    Salud Publica Mex; 2011; 53(4):341-4. PubMed ID: 21986791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbapenem resistance among Escherichia coli and Klebsiella pneumoniae in a tertiary care hospital in south India.
    Nagaraj S; Chandran SP; Shamanna P; Macaden R
    Indian J Med Microbiol; 2012; 30(1):93-5. PubMed ID: 22361769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.